Home › Acute Myeloid Leukemia › New Jersey › Edison
Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Edison, NJ
Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Edison. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Nagre-recruitPhase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
A Study of CRD3874-SI in People With Leukemia
Nagre-recruitPhase 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi ang layo
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Nagre-recruitPhase 3
- Saint Peter's University Hospital, New Brunswick · 3 mi ang layo
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi ang layo
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Saint Peter's University Hospital, New Brunswick · 3 mi ang layo
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi ang layo
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi ang layo
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Nagre-recruitPhase 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Nagre-recruitPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Study of Revumenib and Mezigdomide in People With Leukemia
Nagre-recruitPhase 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi ang layo
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Nagre-recruitPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Nagre-recruitPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Nagre-recruitPhase 1
- Rutgers Cancer Institute, New Brunswick · 3 mi ang layo
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Nagre-recruitPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi ang layo
Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod
- Houston, TX85 pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Baldwin Park, CA40 pag-aaral
- Seattle, WA40 pag-aaral
- Columbus, OH35 pag-aaral
- Philadelphia, PA34 pag-aaral
- Durham, NC33 pag-aaral
- Atlanta, GA30 pag-aaral
- Tampa, FL29 pag-aaral
- Chicago, IL26 pag-aaral
- Portland, OR25 pag-aaral
Iba pang pag-aaral sa Edison
- Kanser sa Suso68 pag-aaral
- Non-Small Cell Lung Cancer47 pag-aaral
- Kanser (lahat ng uri)33 pag-aaral
- Kanser sa Prostate29 pag-aaral
- Colorectal Cancer23 pag-aaral
- Kanser sa Baga23 pag-aaral
- Multiple Myeloma22 pag-aaral
- Kanser sa Pantog21 pag-aaral
- Metastatic Cancer20 pag-aaral
- Kanser sa Ovary20 pag-aaral
- Kanser ng Endometrium19 pag-aaral
- Urothelial (Transitional Cell) Carcinoma18 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.